InvestorsHub Logo
Followers 52
Posts 9087
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Thursday, 05/23/2024 12:21:30 AM

Thursday, May 23, 2024 12:21:30 AM

Post# of 13457
Roy Buchanan – a Citizens JMP analyst expects the news to be significant for $MRNA particularly if the H5N1 strain turns into a worldwide concern.

That’s because the biotech giant has a vaccine currently in a Phase 2 trial that “targets the same evolutionary group as the avian influenza virus” – and it’s convinced that vaccine can be easily adapted to new mutations as well.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News